NCT00793624 - Safety and Efficacy of BI 1744 CL in Patients With Chronic Obstructive Pulmonary Disease I | Biotech Hunter

Enrollment

906

Participants

Timeline

Start Date

February 28, 2009

Primary Completion Date

December 31, 2010

Conditions

Pulmonary Disease, Chronic Obstructive

Interventions

DRUG

Olodaterol (BI 1744)

Comparison of low and high doses on efficacy and safety in COPD patients

DRUG

Olodaterol (BI 1744)

Comparison of low and high doses on efficacy and safety in COPD patients

DRUG

Formoterol

Active comparator with Olodaterol (BI 1744) on safety and efficacy in COPD patients

DRUG

Placebo

Placebo for comparison with Olodaterol (BI 1744) on safety and efficacy in COPD patients

DRUG

Placebo

Placebo for comparison Formoterolon safety and efficacy in COPD patients

Trial Locations (93)

Unknown

1222.13.2401 Boehringer Ingelheim Investigational Site, Capital Federal

1222.13.2403 Boehringer Ingelheim Investigational Site, Capital Federal

1222.13.2402 Boehringer Ingelheim Investigational Site, Mar del Plata

1222.13.2404 Boehringer Ingelheim Investigational Site, Monte Grande

1222.13.2502 Boehringer Ingelheim Investigational Site, Juiz de Fora

1222.13.2503 Boehringer Ingelheim Investigational Site, Rio de Janeiro

1222.13.2505 Boehringer Ingelheim Investigational Site, Rio de Janeiro

1222.13.2501 Boehringer Ingelheim Investigational Site, São Paulo

1222.13.2504 Boehringer Ingelheim Investigational Site, São Paulo

1222.13.1408 Boehringer Ingelheim Investigational Site, Calgary

1222.13.1407 Boehringer Ingelheim Investigational Site, Chilliwack

1222.13.1403 Boehringer Ingelheim Investigational Site, Downsview

1222.13.1412 Boehringer Ingelheim Investigational Site, Hamilton

1222.13.1401 Boehringer Ingelheim Investigational Site, Niagara Falls

1222.13.1410 Boehringer Ingelheim Investigational Site, Sarnia

1222.13.1413 Boehringer Ingelheim Investigational Site, Toronto

1222.13.1404 Boehringer Ingelheim Investigational Site, La Malbaie

1222.13.1411 Boehringer Ingelheim Investigational Site, Montreal

1222.13.1406 Boehringer Ingelheim Investigational Site, Point Claire

1222.13.1402 Boehringer Ingelheim Investigational Site, Saskatoon

1222.13.3502 Boehringer Ingelheim Investigational Site, Dubrovnik

1222.13.3503 Boehringer Ingelheim Investigational Site, Rijeka

1222.13.3504 Boehringer Ingelheim Investigational Site, Split

1222.13.3501 Boehringer Ingelheim Investigational Site, Zagreb

1222.13.3401 Boehringer Ingelheim Investigational Site, Beroun

1222.13.3403 Boehringer Ingelheim Investigational Site, Český Těšín

1222.13.3402 Boehringer Ingelheim Investigational Site, Tábor

1222.13.2003 Boehringer Ingelheim Investigational Site, Aalborg

1222.13.2002 Boehringer Ingelheim Investigational Site, Hvidovre

1222.13.2001 Boehringer Ingelheim Investigational Site, Silkeborg

1222.13.2103 Boehringer Ingelheim Investigational Site, Lahti

1222.13.2101 Boehringer Ingelheim Investigational Site, Tampere

1222.13.2102 Boehringer Ingelheim Investigational Site, Turku

1222.13.1502 Boehringer Ingelheim Investigational Site, Berlin

1222.13.1503 Boehringer Ingelheim Investigational Site, Berlin

1222.13.1506 Boehringer Ingelheim Investigational Site, Berlin

1222.13.1501 Boehringer Ingelheim Investigational Site, Cologne

1222.13.1511 Boehringer Ingelheim Investigational Site, Dortmund

1222.13.1514 Boehringer Ingelheim Investigational Site, Essen

1222.13.1509 Boehringer Ingelheim Investigational Site, Großhansdorf

1222.13.1508 Boehringer Ingelheim Investigational Site, Hanover

1222.13.1510 Boehringer Ingelheim Investigational Site, Hanover

1222.13.1512 Boehringer Ingelheim Investigational Site, Kiel

1222.13.1505 Boehringer Ingelheim Investigational Site, Reinfeld

1222.13.1507 Boehringer Ingelheim Investigational Site, Schwerin

1222.13.2901 Boehringer Ingelheim Investigational Site, Kowloon

1222.13.2804 Boehringer Ingelheim Investigational Site, Bangalore

1222.13.2803 Boehringer Ingelheim Investigational Site, Chennai

1222.13.2806 Boehringer Ingelheim Investigational Site, Coimbatore

1222.13.2810 Boehringer Ingelheim Investigational Site, Hyderabad

1222.13.2801 Boehringer Ingelheim Investigational Site, Indore

1222.13.2807 Boehringer Ingelheim Investigational Site, Indore

1222.13.2805 Boehringer Ingelheim Investigational Site, Jaipur

1222.13.2802 Boehringer Ingelheim Investigational Site, Ludhiana, Punjab

1222.13.2809 Boehringer Ingelheim Investigational Site, Mumbai

1222.13.2812 Boehringer Ingelheim Investigational Site, Mumbai

1222.13.2811 Boehringer Ingelheim Investigational Site, Pune

1222.13.1704 Boehringer Ingelheim Investigational Site, Catania

1222.13.1702 Boehringer Ingelheim Investigational Site, Genova

1222.13.1701 Boehringer Ingelheim Investigational Site, Pisa

1222.13.1705 Boehringer Ingelheim Investigational Site, Siena

1222.13.1703 Boehringer Ingelheim Investigational Site, Trieste

1222.13.3103 Boehringer Ingelheim Investigational Site, Batu Caves

1222.13.3101 Boehringer Ingelheim Investigational Site, Kota Kinabalu

1222.13.3102 Boehringer Ingelheim Investigational Site, Kuala Lumpur

1222.13.3104 Boehringer Ingelheim Investigational Site, Kuantan

1222.13.2201 Boehringer Ingelheim Investigational Site, Bergen

1222.13.2202 Boehringer Ingelheim Investigational Site, Oslo

1222.13.3203 Boehringer Ingelheim Investigational Site, Cebu

1222.13.3201 Boehringer Ingelheim Investigational Site, Quezon City

1222.13.3202 Boehringer Ingelheim Investigational Site, Quezon City

1222.13.2302 Boehringer Ingelheim Investigational Site, Durban

1222.13.2301 Boehringer Ingelheim Investigational Site, Pretoria

1222.13.2701 Boehringer Ingelheim Investigational Site, Gwangju

1222.13.2702 Boehringer Ingelheim Investigational Site, Incheon

1222.13.2703 Boehringer Ingelheim Investigational Site, Seoul

1222.13.2705 Boehringer Ingelheim Investigational Site, Seoul

1222.13.2706 Boehringer Ingelheim Investigational Site, Seoul

1222.13.2704 Boehringer Ingelheim Investigational Site, Suwon

1222.13.1803 Boehringer Ingelheim Investigational Site, Aranjuez

1222.13.1806 Boehringer Ingelheim Investigational Site, Elda

1222.13.1802 Boehringer Ingelheim Investigational Site, els Hostalets de Balenyà

1222.13.1804 Boehringer Ingelheim Investigational Site, Pozuelo de Alarcón

1222.13.1805 Boehringer Ingelheim Investigational Site, Valladolid

1222.13.1801 Boehringer Ingelheim Investigational Site, Vic (Barcelona)

1222.13.1901 Boehringer Ingelheim Investigational Site, Boden

1222.13.1902 Boehringer Ingelheim Investigational Site, Sundsvall

1222.13.3302 Boehringer Ingelheim Investigational Site, Bangkok

1222.13.3303 Boehringer Ingelheim Investigational Site, Bangkok

1222.13.3301 Boehringer Ingelheim Investigational Site, Chiang Mai

1222.13.3602 Boehringer Ingelheim Investigational Site, Ivano-Frankivsk

1222.13.3601 Boehringer Ingelheim Investigational Site, Kharkiv

1222.13.3603 Boehringer Ingelheim Investigational Site, Kiev